X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

Temperature Management For Pharmaceutical Logistics Success

Content Team by Content Team
29th August 2023
in Facilities & Operation, Featured, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The summer of 2023 might become the hottest on record, raising concerns about climate change and the need to prepare for more instances of extreme heat. The occurrence of El Niño, a global weather phenomenon, coupled with high temperatures experienced in different regions during the first half of the year and throughout the summer, has emphasized the urgency of addressing the challenges presented by extreme temperatures. This is especially important to avoid disruptions in the pharmaceutical supply chains.

Conventional methods of transporting essential medications, such as dry ice and one-way styrofoam containers, are inadequate in maintaining the quality and effectiveness of products. When products are suspected of being exposed to temperature fluctuations, they are often discarded, leading to potential shortages for patients. It’s time to embrace innovative temperature-controlled solutions and real-time data monitoring for pharmaceutical logistics.

Within the pharmaceutical sector, failures in maintaining the cold supply chain lead to an estimated annual loss of $35 billion, with many of these losses attributed to logistical shortcomings. Temperature-controlled solutions are designed to endure harsh external conditions and uphold the specific temperature requirements of various products. These solutions encompass refrigeration, deep freezing, and ambient storage capabilities, facilitated by advanced cooling systems and insulation.

Advancements in technology now make real-time data monitoring feasible. By integrating sensors and advanced tracking technologies into temperature-controlled containers, companies can oversee crucial operational factors like temperature, humidity, and other vital indicators. Continuous monitoring allows for the swift identification of deviations from optimal conditions, enabling prompt preventive measures. This not only increases transparency and accountability but also enhances the entire transportation process.

Even with well-executed shipping strategies, the risk of temperature deviations remains. A more proactive approach involves combining simulation data (S data) with real-time operational data (O data).

S data is instrumental in predicting and preventing potential issues beforehand, facilitating proactive problem-solving. By anticipating disruptions, determining optimal shipping routes, and preemptively addressing transit challenges, simulation data safeguards the integrity of pharmaceutical goods. Conversely, real-time O data offers immediate insights into ongoing shipment status, enabling timely interventions when problems arise.

However, the potential of data extends beyond simulations and real-time monitoring. As the impact of hot weather intensifies, innovative solutions are essential for increased resilience and risk reduction. Collecting data directly from patients creates a powerful feedback loop, providing valuable insights into product performance. Equipped with this knowledge, pharmaceutical companies can optimize their supply chains, fine-tune processes to navigate hot weather challenges, and enhance medicine delivery.

Ultimately, the strength of data lies in its capacity to drive continuous improvement across the entire supply chain and enhance the patient experience. Through temperature-controlled solutions and leveraging real-time data monitoring, the industry can establish a robust ecosystem capable of navigating scorching summers and unforeseen disruptions.

Previous Post

Pharma Giants Spearhead Eco-Friendly Healthcare Transition

Next Post

AAV Gene Therapy CDMOs Shaping The Future With A $2.57B Goal

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

AAV Gene Therapy CDMOs Shaping The Future With A $2.57B Goal

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In